Exploration of new technology of personalized neoantigen peptide vaccine in the adjuvant treatment of refractory colorectal cancer patients with recurrence and metastasis

ABSTRACT: Interventions: Case series:Neoplastic antigen peptide vaccine Primary outcome(s): The incidence and severity of adverse events and specific laboratory abnormalities (CTCAE V4.03) in all treated subjects Study Design: Single arm

DISEASE(S): Carcinoma Of Colon And Rectum

PROVIDER: 2696207 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR